|
市場調査レポート
商品コード
1219646
子宮内膜症の世界市場規模・シェア・産業動向分析レポートタイプ別、治療法別（経口避妊薬、ゴナドトロピン放出ホルモン（GnRH）製剤、その他）、流通チャネル別、地域別展望・予測、2022年～2028年版Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
|
|
|||||||
価格
| 子宮内膜症の世界市場規模・シェア・産業動向分析レポートタイプ別、治療法別（経口避妊薬、ゴナドトロピン放出ホルモン（GnRH）製剤、その他）、流通チャネル別、地域別展望・予測、2022年～2028年版 |
|
出版日: 2023年01月31日
発行: KBV Research
ページ情報: 英文 204 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
子宮内膜症の世界市場規模は、2028年には22億米ドルに達し、予測期間中にCAGR11.6%の市場成長率で上昇すると予測されています。
子宮内膜症パッチは「粘着性」の傾向があり、臓器同士をつなぐことがあります。癒着とは、医学用語でこのような状態を指します。例えば、腸や膀胱が子宮に「くっつく」可能性があります。大きな子宮内膜症パッチは、毎月の月経時に出血する嚢胞に発展する可能性があります。この嚢胞は「チョコレート嚢胞」と呼ばれ、黒い血とともに腫れ上がることがあります。
正式な診断がつかないまま、多くの子宮内膜症患者は、症状だけに基づいて治療を受けることになります。場合によっては、腹腔鏡検査という簡単な手術で、確実な診断ができることもあります。この手術では、腹部を小さく切開し（多くの場合1.5cm以下）、そこからカメラを挿入して骨盤内を観察します。生検（小さな組織サンプル）を採取することができます。
COVID-19の影響度分析
COVID-19の大流行は、COVID-19患者のための病院収容力を拡大するために、世界中の医学部や病院を大規模に再編するため、子宮内膜症市場にマイナスの影響を与えると予測されます。パンデミックの間、子宮内膜症治療法の開発と発見は減速しましたが、停止したわけではありません。ヘルスケア業者は、緊急のケースしか受け入れず、重要度の低いケースにはより在宅医療を提案するようになっていました。さらに、生産施設の閉鎖やゼラチンなどの原材料の不足により、子宮内膜症治療薬のサプライチェーンが大きく中断されました。
市場の成長要因
子宮内膜症の認知度を高めるための政府の取り組み
一次医療施設との接続が良好な三次・二次医療施設において、高度な画像診断、薬剤、外科手術、不妊治療、集学的介入を行う紹介ネットワークとケア経路を確立。ツール（超音波や磁気共鳴画像など）や医薬品の利用可能性を高めることで、医療システムが子宮内膜症を早期に発見し治療するための設備を整える（経口複合避妊薬、非ステロイド性鎮痛薬、黄体ホルモンベースの避妊薬など）。市場の成長は、多数の重要な政府機関が認知度を高めるためのプログラムやその他の啓蒙活動を行うことによって後押しされるでしょう。これは、予測期間中の市場成長をますます後押しするものと思われます。
子宮内膜症などの婦人科系疾患の発生率の増加
子宮内膜症は、子宮内膜に類似した組織が子宮の外で増殖し、疼痛や不妊症の原因となる疾患です。世界では、生殖年齢にある女性および青少年の約10％（1億9千万人）が子宮内膜症に罹患しているといわれています。子宮内膜症は、生理中、性行為中、排便・膀胱運動中、慢性的な骨盤の不快感、胃の膨満感、吐き気、疲労感、時にはうつ病や不安感、不妊症などの耐え難い、人生を左右する苦痛を引き起こす慢性疾患です。
市場抑制要因
非侵襲的な子宮内膜症診断検査が存在しないこと。
診断検査の有用性と妥当性は、主に特定の疾患に対する感度と特異性によって決定されます。しかし、これらの指標を理解し、臨床的な意思決定に適用することは、時として困難な場合があります。陽性または陰性の検査が、患者がその疾患に罹患しているかどうかを適切に識別する可能性は、陽性予測値（PPV）または陰性予測値（NPV）として知られています。子宮内膜症市場は、適切かつ効率的な診断装置がないため、緩やかに拡大すると予測されています。
タイプ別展望
子宮内膜症市場は、タイプ別に表在性腹膜病変、子宮内膜腫、その他に区分されます。2021年の子宮内膜症市場では、表在性腹膜病変のセグメントが最も高い収益シェアを獲得しています。これは、表在性腹膜病変の発生率が上昇し、子宮内膜症の認知度を高めるためのプログラムが作成された結果です。さらに、子宮内膜症研究に対する政府の融資の増加が、表在性腹膜病変セグメントの開発を加速させています。
流通経路の展望
子宮内膜症市場は、流通チャネル別に病院薬局、オンライン薬局、小売薬局に分類されます。病院薬局セグメントは、2021年の子宮内膜症市場において最大の収益シェアを示しました。これは、病院薬局の拡大や、高品質なケアの提供者としての病院に対する患者の信頼度の上昇に起因しています。病院薬局市場は、主に手術の代替としての子宮内膜症治療の動向の高まりによって牽引されています。また、病院薬剤師は薬に関する知識が豊富なため、子宮内膜症患者やその介護者が適切な薬を選択する手助けをすることができます。このような要素はすべて、この分野の拡大を後押ししています。
治療分野の展望
子宮内膜症市場は、治療法別に、経口避妊薬、ゴナドトロピン放出ホルモン（GnRH）製剤、その他に二分されます。ゴナドトロピン放出ホルモン（GnRH）薬セグメントは、2021年の子宮内膜症市場において突出した収益シェアを記録しています。これらは、錠剤、注射、注射、点鼻薬として利用可能です。AbbVie Inc.社製のOrilissa（エラゴリクス）は、疾患関連の痛みを緩和するためにFDAの承認を得た最初の薬剤です。第一選択薬に抵抗性を示す患者には、代替薬としてGnRHアゴニストおよびアンタゴニストを検討する必要があります。
地域別の展望
地域別に見ると、子宮内膜症市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年に最大の収益シェアで子宮内膜症市場を独占しました。これは主に、ゴナドトロピン放出ホルモン（GnRH）薬などの追加治療が必要となる子宮内膜症患者の増加、子宮内膜症研究のための政府出資の増加、先進国における資本所得の大幅な増加などに関連するものです。また、償還制度が洗練され、支出水準を下げるように設計されていることも、市場の拡大に寄与しています。
目次
第1章 市場の範囲と調査手法
- 市場の定義
- 目的
- 市場規模
- セグメンテーション
- 子宮内膜症の世界市場、タイプ別
- 子宮内膜症の世界市場、治療法別
- 子宮内膜症の世界市場、流通チャネル別
- 子宮内膜症の世界市場、地域別
- 調査手法
第2章 市場概要
- イントロダクション
- 概要説明
- 市場の構成とシナリオ
- 概要説明
- 市場に影響を与える主な要因
- 市場促進要因
- 市場の抑制要因
第3章 子宮内膜症の世界市場：タイプ別
- 表在性腹膜病変の世界市場：地域別
- 子宮内膜腫の世界市場：地域別
- 世界のその他地域別市場
第4章 子宮内膜症の世界市場：治療法別
- 経口避妊薬の世界市場：地域別
- ゴナドトロピン放出ホルモン（GnRH）製剤の世界市場：地域別
- その他の世界市場：地域別
第5章 子宮内膜症の世界市場：流通チャネル別
- 病院内薬局の世界市場：地域別
- 小売薬局の世界市場：地域別
- オンライン薬局の世界市場：地域別
第6章 子宮内膜症の世界市場：地域別
- 北米
- 北米の国別子宮内膜症市場
- 米国
- カナダ
- メキシコ
- その他北米地域
- 北米の国別子宮内膜症市場
- 欧州
- 欧州の子宮内膜症市場：国別
- ドイツ
- 英国
- フランス
- ロシア
- スペイン
- イタリア
- その他欧州
- 欧州の子宮内膜症市場：国別
- アジア太平洋地域
- アジア太平洋地域の国別子宮内膜症市場
- 中国
- 日本
- インド
- 韓国
- シンガポール
- マレーシア
- その他アジア太平洋地域
- アジア太平洋地域の国別子宮内膜症市場
- LAMEA
- LAMEAの子宮内膜症市場：国別
- ブラジル
- アルゼンチン
- UAE
- サウジアラビア
- 南アフリカ
- ナイジェリア
- その他のLAMEA
- LAMEAの子宮内膜症市場：国別
第7章 企業プロファイル
- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A
- AbbVie, Inc.
- AstraZeneca PLC
- Pfizer, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Consilient Health Limited
図表
LIST OF TABLES
- TABLE 1 Global Endometriosis Market, 2018 - 2021, USD Million
- TABLE 2 Global Endometriosis Market, 2022 - 2028, USD Million
- TABLE 3 Global Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 4 Global Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 5 Global Superficial Peritoneal Lesion Market by Region, 2018 - 2021, USD Million
- TABLE 6 Global Superficial Peritoneal Lesion Market by Region, 2022 - 2028, USD Million
- TABLE 7 Global Endometriomas Market by Region, 2018 - 2021, USD Million
- TABLE 8 Global Endometriomas Market by Region, 2022 - 2028, USD Million
- TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
- TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
- TABLE 11 Global Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 12 Global Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 13 Global Oral Contraceptives Market by Region, 2018 - 2021, USD Million
- TABLE 14 Global Oral Contraceptives Market by Region, 2022 - 2028, USD Million
- TABLE 15 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2018 - 2021, USD Million
- TABLE 16 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2022 - 2028, USD Million
- TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
- TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
- TABLE 19 Global Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 20 Global Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 21 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
- TABLE 22 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
- TABLE 23 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
- TABLE 24 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
- TABLE 25 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
- TABLE 26 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
- TABLE 27 Global Endometriosis Market by Region, 2018 - 2021, USD Million
- TABLE 28 Global Endometriosis Market by Region, 2022 - 2028, USD Million
- TABLE 29 North America Endometriosis Market, 2018 - 2021, USD Million
- TABLE 30 North America Endometriosis Market, 2022 - 2028, USD Million
- TABLE 31 North America Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 32 North America Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 33 North America Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
- TABLE 34 North America Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
- TABLE 35 North America Endometriomas Market by Country, 2018 - 2021, USD Million
- TABLE 36 North America Endometriomas Market by Country, 2022 - 2028, USD Million
- TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 39 North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 40 North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 41 North America Oral Contraceptives Market by Country, 2018 - 2021, USD Million
- TABLE 42 North America Oral Contraceptives Market by Country, 2022 - 2028, USD Million
- TABLE 43 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
- TABLE 44 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
- TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 47 North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 48 North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 49 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 50 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 51 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 52 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 53 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 54 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 55 North America Endometriosis Market by Country, 2018 - 2021, USD Million
- TABLE 56 North America Endometriosis Market by Country, 2022 - 2028, USD Million
- TABLE 57 US Endometriosis Market, 2018 - 2021, USD Million
- TABLE 58 US Endometriosis Market, 2022 - 2028, USD Million
- TABLE 59 US Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 60 US Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 61 US Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 62 US Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 63 US Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 64 US Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 65 Canada Endometriosis Market, 2018 - 2021, USD Million
- TABLE 66 Canada Endometriosis Market, 2022 - 2028, USD Million
- TABLE 67 Canada Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 68 Canada Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 69 Canada Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 70 Canada Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 71 Canada Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 72 Canada Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 73 Mexico Endometriosis Market, 2018 - 2021, USD Million
- TABLE 74 Mexico Endometriosis Market, 2022 - 2028, USD Million
- TABLE 75 Mexico Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 76 Mexico Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 77 Mexico Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 78 Mexico Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 79 Mexico Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 80 Mexico Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 81 Rest of North America Endometriosis Market, 2018 - 2021, USD Million
- TABLE 82 Rest of North America Endometriosis Market, 2022 - 2028, USD Million
- TABLE 83 Rest of North America Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 84 Rest of North America Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 85 Rest of North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 86 Rest of North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 87 Rest of North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 88 Rest of North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 89 Europe Endometriosis Market, 2018 - 2021, USD Million
- TABLE 90 Europe Endometriosis Market, 2022 - 2028, USD Million
- TABLE 91 Europe Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 92 Europe Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 93 Europe Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
- TABLE 94 Europe Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
- TABLE 95 Europe Endometriomas Market by Country, 2018 - 2021, USD Million
- TABLE 96 Europe Endometriomas Market by Country, 2022 - 2028, USD Million
- TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 99 Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 100 Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 101 Europe Oral Contraceptives Market by Country, 2018 - 2021, USD Million
- TABLE 102 Europe Oral Contraceptives Market by Country, 2022 - 2028, USD Million
- TABLE 103 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
- TABLE 104 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
- TABLE 105 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 106 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 107 Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 108 Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 109 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 110 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 111 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 112 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 115 Europe Endometriosis Market by Country, 2018 - 2021, USD Million
- TABLE 116 Europe Endometriosis Market by Country, 2022 - 2028, USD Million
- TABLE 117 Germany Endometriosis Market, 2018 - 2021, USD Million
- TABLE 118 Germany Endometriosis Market, 2022 - 2028, USD Million
- TABLE 119 Germany Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 120 Germany Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 121 Germany Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 122 Germany Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 123 Germany Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 124 Germany Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 125 UK Endometriosis Market, 2018 - 2021, USD Million
- TABLE 126 UK Endometriosis Market, 2022 - 2028, USD Million
- TABLE 127 UK Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 128 UK Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 129 UK Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 130 UK Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 131 UK Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 132 UK Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 133 France Endometriosis Market, 2018 - 2021, USD Million
- TABLE 134 France Endometriosis Market, 2022 - 2028, USD Million
- TABLE 135 France Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 136 France Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 137 France Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 138 France Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 139 France Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 140 France Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 141 Russia Endometriosis Market, 2018 - 2021, USD Million
- TABLE 142 Russia Endometriosis Market, 2022 - 2028, USD Million
- TABLE 143 Russia Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 144 Russia Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 145 Russia Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 146 Russia Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 147 Russia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 148 Russia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 149 Spain Endometriosis Market, 2018 - 2021, USD Million
- TABLE 150 Spain Endometriosis Market, 2022 - 2028, USD Million
- TABLE 151 Spain Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 152 Spain Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 153 Spain Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 154 Spain Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 155 Spain Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 156 Spain Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 157 Italy Endometriosis Market, 2018 - 2021, USD Million
- TABLE 158 Italy Endometriosis Market, 2022 - 2028, USD Million
- TABLE 159 Italy Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 160 Italy Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 161 Italy Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 162 Italy Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 163 Italy Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 164 Italy Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 165 Rest of Europe Endometriosis Market, 2018 - 2021, USD Million
- TABLE 166 Rest of Europe Endometriosis Market, 2022 - 2028, USD Million
- TABLE 167 Rest of Europe Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 168 Rest of Europe Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 169 Rest of Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 170 Rest of Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 171 Rest of Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 172 Rest of Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 173 Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
- TABLE 174 Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
- TABLE 175 Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 176 Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 177 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
- TABLE 178 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
- TABLE 179 Asia Pacific Endometriomas Market by Country, 2018 - 2021, USD Million
- TABLE 180 Asia Pacific Endometriomas Market by Country, 2022 - 2028, USD Million
- TABLE 181 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 182 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 183 Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 184 Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 185 Asia Pacific Oral Contraceptives Market by Country, 2018 - 2021, USD Million
- TABLE 186 Asia Pacific Oral Contraceptives Market by Country, 2022 - 2028, USD Million
- TABLE 187 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
- TABLE 188 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
- TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 191 Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 192 Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 195 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 196 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 197 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 198 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 199 Asia Pacific Endometriosis Market by Country, 2018 - 2021, USD Million
- TABLE 200 Asia Pacific Endometriosis Market by Country, 2022 - 2028, USD Million
- TABLE 201 China Endometriosis Market, 2018 - 2021, USD Million
- TABLE 202 China Endometriosis Market, 2022 - 2028, USD Million
- TABLE 203 China Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 204 China Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 205 China Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 206 China Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 207 China Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 208 China Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 209 Japan Endometriosis Market, 2018 - 2021, USD Million
- TABLE 210 Japan Endometriosis Market, 2022 - 2028, USD Million
- TABLE 211 Japan Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 212 Japan Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 213 Japan Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 214 Japan Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 215 Japan Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 216 Japan Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 217 India Endometriosis Market, 2018 - 2021, USD Million
- TABLE 218 India Endometriosis Market, 2022 - 2028, USD Million
- TABLE 219 India Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 220 India Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 221 India Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 222 India Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 223 India Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 224 India Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 225 South Korea Endometriosis Market, 2018 - 2021, USD Million
- TABLE 226 South Korea Endometriosis Market, 2022 - 2028, USD Million
- TABLE 227 South Korea Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 228 South Korea Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 229 South Korea Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 230 South Korea Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 231 South Korea Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 232 South Korea Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 233 Singapore Endometriosis Market, 2018 - 2021, USD Million
- TABLE 234 Singapore Endometriosis Market, 2022 - 2028, USD Million
- TABLE 235 Singapore Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 236 Singapore Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 237 Singapore Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 238 Singapore Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 239 Singapore Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 240 Singapore Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 241 Malaysia Endometriosis Market, 2018 - 2021, USD Million
- TABLE 242 Malaysia Endometriosis Market, 2022 - 2028, USD Million
- TABLE 243 Malaysia Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 244 Malaysia Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 245 Malaysia Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 246 Malaysia Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 247 Malaysia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 248 Malaysia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 249 Rest of Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
- TABLE 250 Rest of Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
- TABLE 251 Rest of Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 252 Rest of Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 253 Rest of Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 254 Rest of Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 255 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 256 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 257 LAMEA Endometriosis Market, 2018 - 2021, USD Million
- TABLE 258 LAMEA Endometriosis Market, 2022 - 2028, USD Million
- TABLE 259 LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 260 LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 261 LAMEA Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
- TABLE 262 LAMEA Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
- TABLE 263 LAMEA Endometriomas Market by Country, 2018 - 2021, USD Million
- TABLE 264 LAMEA Endometriomas Market by Country, 2022 - 2028, USD Million
- TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 267 LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 268 LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 269 LAMEA Oral Contraceptives Market by Country, 2018 - 2021, USD Million
- TABLE 270 LAMEA Oral Contraceptives Market by Country, 2022 - 2028, USD Million
- TABLE 271 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
- TABLE 272 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
- TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 275 LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 276 LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 277 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 278 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 279 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 280 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 283 LAMEA Endometriosis Market by Country, 2018 - 2021, USD Million
- TABLE 284 LAMEA Endometriosis Market by Country, 2022 - 2028, USD Million
- TABLE 285 Brazil Endometriosis Market, 2018 - 2021, USD Million
- TABLE 286 Brazil Endometriosis Market, 2022 - 2028, USD Million
- TABLE 287 Brazil Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 288 Brazil Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 289 Brazil Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 290 Brazil Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 291 Brazil Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 292 Brazil Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 293 Argentina Endometriosis Market, 2018 - 2021, USD Million
- TABLE 294 Argentina Endometriosis Market, 2022 - 2028, USD Million
- TABLE 295 Argentina Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 296 Argentina Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 297 Argentina Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 298 Argentina Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 299 Argentina Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 300 Argentina Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 301 UAE Endometriosis Market, 2018 - 2021, USD Million
- TABLE 302 UAE Endometriosis Market, 2022 - 2028, USD Million
- TABLE 303 UAE Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 304 UAE Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 305 UAE Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 306 UAE Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 307 UAE Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 308 UAE Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 309 Saudi Arabia Endometriosis Market, 2018 - 2021, USD Million
- TABLE 310 Saudi Arabia Endometriosis Market, 2022 - 2028, USD Million
- TABLE 311 Saudi Arabia Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 312 Saudi Arabia Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 313 Saudi Arabia Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 314 Saudi Arabia Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 315 Saudi Arabia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 316 Saudi Arabia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 317 South Africa Endometriosis Market, 2018 - 2021, USD Million
- TABLE 318 South Africa Endometriosis Market, 2022 - 2028, USD Million
- TABLE 319 South Africa Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 320 South Africa Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 321 South Africa Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 322 South Africa Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 323 South Africa Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 324 South Africa Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 325 Nigeria Endometriosis Market, 2018 - 2021, USD Million
- TABLE 326 Nigeria Endometriosis Market, 2022 - 2028, USD Million
- TABLE 327 Nigeria Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 328 Nigeria Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 329 Nigeria Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 330 Nigeria Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 331 Nigeria Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 332 Nigeria Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 333 Rest of LAMEA Endometriosis Market, 2018 - 2021, USD Million
- TABLE 334 Rest of LAMEA Endometriosis Market, 2022 - 2028, USD Million
- TABLE 335 Rest of LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
- TABLE 336 Rest of LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
- TABLE 337 Rest of LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
- TABLE 338 Rest of LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
- TABLE 339 Rest of LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 340 Rest of LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 341 Key Information - Abbott Laboratories
- TABLE 342 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 343 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 344 Key Information - Sanofi S.A.
- TABLE 345 Key information - AbbVie, Inc.
- TABLE 346 KEY INFORMATION - AstraZeneca PLC
- TABLE 347 Key Information - Pfizer, Inc.
- TABLE 348 KEY INFORMATION - Merck & Co., Inc.
- TABLE 349 Key Information - GlaxoSmithKline PLC
- TABLE 350 Key Information - Consilient Health Limited
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Global Endometriosis Market share by Type, 2021
- FIG 3 Global Endometriosis Market share by Type, 2028
- FIG 4 Global Endometriosis Market by Type, 2018 - 2028, USD Million
- FIG 5 Global Endometriosis Market share by Treatment, 2021
- FIG 6 Global Endometriosis Market share by Treatment, 2028
- FIG 7 Global Endometriosis Market by Treatment, 2018 - 2028, USD Million
- FIG 8 Global Endometriosis Market share by Distribution Channel, 2021
- FIG 9 Global Endometriosis Market share by Distribution Channel, 2028
- FIG 10 Global Endometriosis Market by Distribution Channel, 2018 - 2028, USD Million
- FIG 11 Global Endometriosis Market share by Region, 2021
- FIG 12 Global Endometriosis Market share by Region, 2028
- FIG 13 Global Endometriosis Market by Region, 2018 - 2028, USD Million
- FIG 14 Swot analysis: Abbott laboratories
目次
The Global Endometriosis Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.6% CAGR during the forecast period.
Endometrial-like tissue that arises in unintended places is a typical symptom of endometriosis. The tissue that develops and sheds in the uterus is known as endometrial tissue. The majority of the time, this growth occurs on and around pelvic cavity organs. Similar to the tissue inside the uterus, endometrial tissue undergoes growth, thickening, and attempts at shedding with each menstrual cycle.
The tissue can result in adhesions, tumors, and lesions that set off an inflammatory reaction since it has no way to leave the body. This may result in discomfort and other issues, such as infertility. Over the years, various causes of endometriosis have been proposed. The endometrium is the name for the lining of the uterus. According to one notion, endometrial cells can go from the uterus to the pelvic region. When a patient has a period, they pour backward along the Fallopian tubes and end up there.
Endometriosis patches have a tendency to be "sticky" and can connect organs. Adhesions are the medical word for this. The gut or bladder, for instance, could "stuck" to the uterus. Large endometriosis patches might develop into cysts that bleed every month during menstruation. The cysts are referred to as "chocolate cysts" and might swell up with black blood.
Without a formal diagnosis, many endometriosis patients receive treatment based solely on their symptoms. In some instances, a laparoscopy, a straightforward surgery, is used to provide an authoritative diagnosis. In this operation, a tiny abdominal incision (often less than 1.5cm/0.6 inches) is made, through which a camera is inserted to view the pelvic cavity. Biopsies, or small tissue samples, can be taken.
COVID-19 Impact Analysis
The COVID-19 outbreak is projected to have a negative effect on the endometriosis market due to the massive restructuring of medical schools and hospitals around the world to expand hospital capacity for COVID-19 patients. During the pandemic, the development and discovery of endometriosis treatments slowed but did not stop. Healthcare providers were only accepting emergency cases and suggested home care more to the less important cases. Moreover, the shutdown of production facilities and the lack of raw materials like gelatin significantly interrupted the supply chain for endometriosis medications.
Market Growth Factors
Government efforts to raise endometriosis awareness
Establishing referral networks and care pathways with advanced imaging, pharmaceutical, surgical, fertility, and multidisciplinary interventions at tertiary and secondary centers with good connections to primary healthcare facilities. Increasing the availability of tools (such as ultrasound or magnetic resonance imaging) and medications will help health systems be better equipped to detect and treat endometriosis early (e.g., combined oral contraceptives, non-steroidal analgesics, and progestin-based contraceptives). The market growth will be boosted by numerous significant governmental entities conducting programs and other awareness programs to raise awareness. This would increasingly support the market growth during the projection period.
Increasing incidence of gynecological disorders such as endometriosis
Endometriosis is a condition in which tissue that resembles the uterine lining grows outside of the uterus, resulting in pain and/or infertility. Around 10% (190 million) of women and adolescents of reproductive age suffer from endometriosis worldwide. It is a chronic condition that causes excruciating, life-altering agony during periods, sexual activity, bowel and/or bladder movements, chronic pelvic discomfort, stomach bloating, nausea, exhaustion, and occasionally depression, anxiety, and infertility.
Market Restraining Factors
The absence of non-invasive endometriosis diagnostic tests
A diagnostic test's usefulness and validity are primarily determined by its sensitivity and specificity for a certain ailment. However, it can occasionally be challenging to comprehend and apply these measures to clinical decision-making. The likelihood that a positive or negative test would properly identify whether a patient has the condition is known as the positive predictive value (PPV) or negative predictive value (NPV). The endometriosis market is predicted to experience slow expansion due to the absence of appropriate and efficient diagnosis devices.
Type Outlook
Based on type, the endometriosis market is segmented into superficial peritoneal lesion, endometriomas and others. The superficial peritoneal lesion segment generated the highest revenue share in the endometriosis market in 2021. This is a result of the increase in the incidence of superficial peritoneal lesions and the creation of programs to raise endometriosis awareness. Additionally, a rise in government financing for endometriosis research has accelerated the development of the superficial peritoneal lesion segment.
Distribution Channel Outlook
On the basis of distribution channel, the endometriosis market is categorized into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the endometriosis market in 2021. This is due to an expansion in hospital pharmacies and a rise in patients' confidence in hospitals as providers of high-quality care. The hospital pharmacy market is primarily driven by the growing trend of endometriosis therapy as an alternative to surgery. Hospital pharmacists can also help endometriosis patients, and their carers choose the right medications because they are knowledgeable about medications. Such elements all encourage sector expansion.
Treatment Outlook
By treatment, the endometriosis market is bifurcated into oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines and others. The gonadotropin-releasing hormone (GnRH) medicines segment recorded a prominent revenue share in the endometriosis market in 2021. They are available as a tablet, injection, shot, or nasal spray. Orilissa (elagolix), manufactured by AbbVie Inc., was the first drug given FDA approval to alleviate disease-related pain. Patients who are resistant to the first line of treatment should consider GnRH agonists and antagonists as alternatives.
Regional Outlook
Region wise, the endometriosis market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region dominated the endometriosis market with maximum revenue share in 2021. This is mostly linked to an increase in endometriosis cases, which necessitate additional treatments such as gonadotropin-releasing hormone (GnRH) medications, an increase in government financing for endometriosis research, and a considerable increase in capital income in developed countries. The sophisticated reimbursement structures that exist and are designed to lower expenditure levels also contribute to the market's expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
Scope of the Study
Market Segments covered in the Report:
By Type
- Superficial Peritoneal Lesion
- Endometriomas
- Others
By Treatment
- Oral Contraceptives
- Gonadotropin-releasing hormone (GnRH) medicines
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A.
- AbbVie, Inc.
- AstraZeneca PLC
- Pfizer, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Abbott Laboratories
- Consilient Health Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Endometriosis Market, by Type
- 1.4.2 Global Endometriosis Market, by Treatment
- 1.4.3 Global Endometriosis Market, by Distribution Channel
- 1.4.4 Global Endometriosis Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Global Endometriosis Market by Type
- 3.1 Global Superficial Peritoneal Lesion Market by Region
- 3.2 Global Endometriomas Market by Region
- 3.3 Global Others Market by Region
Chapter 4. Global Endometriosis Market by Treatment
- 4.1 Global Oral Contraceptives Market by Region
- 4.2 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region
- 4.3 Global Others Market by Region
Chapter 5. Global Endometriosis Market by Distribution Channel
- 5.1 Global Hospital Pharmacy Market by Region
- 5.2 Global Retail Pharmacy Market by Region
- 5.3 Global Online Pharmacy Market by Region
Chapter 6. Global Endometriosis Market by Region
- 6.1 North America Endometriosis Market
- 6.1.1 North America Endometriosis Market by Type
- 6.1.1.1 North America Superficial Peritoneal Lesion Market by Country
- 6.1.1.2 North America Endometriomas Market by Country
- 6.1.1.3 North America Others Market by Country
- 6.1.2 North America Endometriosis Market by Treatment
- 6.1.2.1 North America Oral Contraceptives Market by Country
- 6.1.2.2 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country
- 6.1.2.3 North America Others Market by Country
- 6.1.3 North America Endometriosis Market by Distribution Channel
- 6.1.3.1 North America Hospital Pharmacy Market by Country
- 6.1.3.2 North America Retail Pharmacy Market by Country
- 6.1.3.3 North America Online Pharmacy Market by Country
- 6.1.4 North America Endometriosis Market by Country
- 6.1.4.1 US Endometriosis Market
- 6.1.4.1.1 US Endometriosis Market by Type
- 6.1.4.1.2 US Endometriosis Market by Treatment
- 6.1.4.1.3 US Endometriosis Market by Distribution Channel
- 6.1.4.2 Canada Endometriosis Market
- 6.1.4.2.1 Canada Endometriosis Market by Type
- 6.1.4.2.2 Canada Endometriosis Market by Treatment
- 6.1.4.2.3 Canada Endometriosis Market by Distribution Channel
- 6.1.4.3 Mexico Endometriosis Market
- 6.1.4.3.1 Mexico Endometriosis Market by Type
- 6.1.4.3.2 Mexico Endometriosis Market by Treatment
- 6.1.4.3.3 Mexico Endometriosis Market by Distribution Channel
- 6.1.4.4 Rest of North America Endometriosis Market
- 6.1.4.4.1 Rest of North America Endometriosis Market by Type
- 6.1.4.4.2 Rest of North America Endometriosis Market by Treatment
- 6.1.4.4.3 Rest of North America Endometriosis Market by Distribution Channel
- 6.1.4.1 US Endometriosis Market
- 6.1.1 North America Endometriosis Market by Type
- 6.2 Europe Endometriosis Market
- 6.2.1 Europe Endometriosis Market by Type
- 6.2.1.1 Europe Superficial Peritoneal Lesion Market by Country
- 6.2.1.2 Europe Endometriomas Market by Country
- 6.2.1.3 Europe Others Market by Country
- 6.2.2 Europe Endometriosis Market by Treatment
- 6.2.2.1 Europe Oral Contraceptives Market by Country
- 6.2.2.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
- 6.2.2.3 Europe Others Market by Country
- 6.2.3 Europe Endometriosis Market by Distribution Channel
- 6.2.3.1 Europe Hospital Pharmacy Market by Country
- 6.2.3.2 Europe Retail Pharmacy Market by Country
- 6.2.3.3 Europe Online Pharmacy Market by Country
- 6.2.4 Europe Endometriosis Market by Country
- 6.2.4.1 Germany Endometriosis Market
- 6.2.4.1.1 Germany Endometriosis Market by Type
- 6.2.4.1.2 Germany Endometriosis Market by Treatment
- 6.2.4.1.3 Germany Endometriosis Market by Distribution Channel
- 6.2.4.2 UK Endometriosis Market
- 6.2.4.2.1 UK Endometriosis Market by Type
- 6.2.4.2.2 UK Endometriosis Market by Treatment
- 6.2.4.2.3 UK Endometriosis Market by Distribution Channel
- 6.2.4.3 France Endometriosis Market
- 6.2.4.3.1 France Endometriosis Market by Type
- 6.2.4.3.2 France Endometriosis Market by Treatment
- 6.2.4.3.3 France Endometriosis Market by Distribution Channel
- 6.2.4.4 Russia Endometriosis Market
- 6.2.4.4.1 Russia Endometriosis Market by Type
- 6.2.4.4.2 Russia Endometriosis Market by Treatment
- 6.2.4.4.3 Russia Endometriosis Market by Distribution Channel
- 6.2.4.5 Spain Endometriosis Market
- 6.2.4.5.1 Spain Endometriosis Market by Type
- 6.2.4.5.2 Spain Endometriosis Market by Treatment
- 6.2.4.5.3 Spain Endometriosis Market by Distribution Channel
- 6.2.4.6 Italy Endometriosis Market
- 6.2.4.6.1 Italy Endometriosis Market by Type
- 6.2.4.6.2 Italy Endometriosis Market by Treatment
- 6.2.4.6.3 Italy Endometriosis Market by Distribution Channel
- 6.2.4.7 Rest of Europe Endometriosis Market
- 6.2.4.7.1 Rest of Europe Endometriosis Market by Type
- 6.2.4.7.2 Rest of Europe Endometriosis Market by Treatment
- 6.2.4.7.3 Rest of Europe Endometriosis Market by Distribution Channel
- 6.2.4.1 Germany Endometriosis Market
- 6.2.1 Europe Endometriosis Market by Type
- 6.3 Asia Pacific Endometriosis Market
- 6.3.1 Asia Pacific Endometriosis Market by Type
- 6.3.1.1 Asia Pacific Superficial Peritoneal Lesion Market by Country
- 6.3.1.2 Asia Pacific Endometriomas Market by Country
- 6.3.1.3 Asia Pacific Others Market by Country
- 6.3.2 Asia Pacific Endometriosis Market by Treatment
- 6.3.2.1 Asia Pacific Oral Contraceptives Market by Country
- 6.3.2.2 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country
- 6.3.2.3 Asia Pacific Others Market by Country
- 6.3.3 Asia Pacific Endometriosis Market by Distribution Channel
- 6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
- 6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
- 6.3.3.3 Asia Pacific Online Pharmacy Market by Country
- 6.3.4 Asia Pacific Endometriosis Market by Country
- 6.3.4.1 China Endometriosis Market
- 6.3.4.1.1 China Endometriosis Market by Type
- 6.3.4.1.2 China Endometriosis Market by Treatment
- 6.3.4.1.3 China Endometriosis Market by Distribution Channel
- 6.3.4.2 Japan Endometriosis Market
- 6.3.4.2.1 Japan Endometriosis Market by Type
- 6.3.4.2.2 Japan Endometriosis Market by Treatment
- 6.3.4.2.3 Japan Endometriosis Market by Distribution Channel
- 6.3.4.3 India Endometriosis Market
- 6.3.4.3.1 India Endometriosis Market by Type
- 6.3.4.3.2 India Endometriosis Market by Treatment
- 6.3.4.3.3 India Endometriosis Market by Distribution Channel
- 6.3.4.4 South Korea Endometriosis Market
- 6.3.4.4.1 South Korea Endometriosis Market by Type
- 6.3.4.4.2 South Korea Endometriosis Market by Treatment
- 6.3.4.4.3 South Korea Endometriosis Market by Distribution Channel
- 6.3.4.5 Singapore Endometriosis Market
- 6.3.4.5.1 Singapore Endometriosis Market by Type
- 6.3.4.5.2 Singapore Endometriosis Market by Treatment
- 6.3.4.5.3 Singapore Endometriosis Market by Distribution Channel
- 6.3.4.6 Malaysia Endometriosis Market
- 6.3.4.6.1 Malaysia Endometriosis Market by Type
- 6.3.4.6.2 Malaysia Endometriosis Market by Treatment
- 6.3.4.6.3 Malaysia Endometriosis Market by Distribution Channel
- 6.3.4.7 Rest of Asia Pacific Endometriosis Market
- 6.3.4.7.1 Rest of Asia Pacific Endometriosis Market by Type
- 6.3.4.7.2 Rest of Asia Pacific Endometriosis Market by Treatment
- 6.3.4.7.3 Rest of Asia Pacific Endometriosis Market by Distribution Channel
- 6.3.4.1 China Endometriosis Market
- 6.3.1 Asia Pacific Endometriosis Market by Type
- 6.4 LAMEA Endometriosis Market
- 6.4.1 LAMEA Endometriosis Market by Type
- 6.4.1.1 LAMEA Superficial Peritoneal Lesion Market by Country
- 6.4.1.2 LAMEA Endometriomas Market by Country
- 6.4.1.3 LAMEA Others Market by Country
- 6.4.2 LAMEA Endometriosis Market by Treatment
- 6.4.2.1 LAMEA Oral Contraceptives Market by Country
- 6.4.2.2 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country
- 6.4.2.3 LAMEA Others Market by Country
- 6.4.3 LAMEA Endometriosis Market by Distribution Channel
- 6.4.3.1 LAMEA Hospital Pharmacy Market by Country
- 6.4.3.2 LAMEA Retail Pharmacy Market by Country
- 6.4.3.3 LAMEA Online Pharmacy Market by Country
- 6.4.4 LAMEA Endometriosis Market by Country
- 6.4.4.1 Brazil Endometriosis Market
- 6.4.4.1.1 Brazil Endometriosis Market by Type
- 6.4.4.1.2 Brazil Endometriosis Market by Treatment
- 6.4.4.1.3 Brazil Endometriosis Market by Distribution Channel
- 6.4.4.2 Argentina Endometriosis Market
- 6.4.4.2.1 Argentina Endometriosis Market by Type
- 6.4.4.2.2 Argentina Endometriosis Market by Treatment
- 6.4.4.2.3 Argentina Endometriosis Market by Distribution Channel
- 6.4.4.3 UAE Endometriosis Market
- 6.4.4.3.1 UAE Endometriosis Market by Type
- 6.4.4.3.2 UAE Endometriosis Market by Treatment
- 6.4.4.3.3 UAE Endometriosis Market by Distribution Channel
- 6.4.4.4 Saudi Arabia Endometriosis Market
- 6.4.4.4.1 Saudi Arabia Endometriosis Market by Type
- 6.4.4.4.2 Saudi Arabia Endometriosis Market by Treatment
- 6.4.4.4.3 Saudi Arabia Endometriosis Market by Distribution Channel
- 6.4.4.5 South Africa Endometriosis Market
- 6.4.4.5.1 South Africa Endometriosis Market by Type
- 6.4.4.5.2 South Africa Endometriosis Market by Treatment
- 6.4.4.5.3 South Africa Endometriosis Market by Distribution Channel
- 6.4.4.6 Nigeria Endometriosis Market
- 6.4.4.6.1 Nigeria Endometriosis Market by Type
- 6.4.4.6.2 Nigeria Endometriosis Market by Treatment
- 6.4.4.6.3 Nigeria Endometriosis Market by Distribution Channel
- 6.4.4.7 Rest of LAMEA Endometriosis Market
- 6.4.4.7.1 Rest of LAMEA Endometriosis Market by Type
- 6.4.4.7.2 Rest of LAMEA Endometriosis Market by Treatment
- 6.4.4.7.3 Rest of LAMEA Endometriosis Market by Distribution Channel
- 6.4.4.1 Brazil Endometriosis Market
- 6.4.1 LAMEA Endometriosis Market by Type
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Teva Pharmaceutical Industries Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.3 Sun Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.4 Sanofi S.A.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.5 AbbVie, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Trials and Approvals:
- 7.6 AstraZeneca PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.7 Pfizer, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional & Segmental Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Partnerships, Collaborations, and Agreements:
- 7.7.5.2 Trials and Approvals:
- 7.8 Merck & Co., Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Trials and Approvals:
- 7.9 GlaxoSmithKline PLC
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.9.5 Recent strategies and developments:
- 7.9.5.1 Trials and Approvals:
- 7.9.5.2 Acquisition and Mergers:
- 7.10. Consilient Health Limited
- 7.10.1 Company Overview
